Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Epidemiology and Population Health

The correlation between serum inflammatory, antioxidant, glucose handling biomarkers, and Dietary Antioxidant Index (DAI) and the role of DAI in obesity/overweight causation: population-based case–control study

Abstract

Background

Obesity is a multifactorial disease, and about 40% of world adults are overweight, and about 20% are obese. Diet is one of the most important factors in the causality of obesity. The interactions between the diet and gut microbiota or chronic inflammation pathways highlight the importance of its various aspects in the incidence and prevalence of obesity. At the same time, diet is a combination of several antioxidants that are needed together for the body’s antioxidant system. The Dietary Antioxidant Index (DAI) is a valid nutritional tool, and its correlation has been studied concerning total antioxidant capacity and malondialdehyde. The study aimed to examine the relationship between the DAI and the odds of obesity. We hypothesized that a higher DAI score indicating a predominantly antioxidant diet has a protective effect against odds of obesity.

Methods

In this population-based case–control study, 812 participants with a higher body mass index (BMI) than 25 were selected as the case group. Also, 793 participants with BMI in the range of 17.9–24.9 were selected as the control group. A valid and reliable 124-item food frequency questionnaire (FFQ) was used to assess dietary intake. Based on FFQ data, we summed up the standardized intake of the major dietary antioxidants, including vitamin A, E, C, selenium, zinc, and manganese, to calculate DAI.

Results

In a multivariable adjusting model, there was a significant association between DAI (as a continuous variable) and BMI (odds ratio (OR) = 0.95; 95% CI: 0.92–0.99; P value = 0.02). Also, there was a significant association between DAI (as a categorized variable) and body surface area with multivariable adjusting model (OR = 0.79; 95% CI: 0.64–0.98; P value = 0.04).

Conclusion

In conclusion, the DAI can accurately predict some serum antioxidant and anti-inflammatory levels along with glucose handling markers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Data availability

Data described in the manuscript, codebook, and analytic code will be made available upon request pending.

References

  1. Rössner S. Obesity: the disease of the twenty-first century. Int J Obes. 2002;26:S2–S4.

    Article  Google Scholar 

  2. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev. 2007;29:1–5.

    Article  Google Scholar 

  3. McLellan F. Obesity rising to alarming levels around the world. Lancet. 2002;359:1412.

    Article  Google Scholar 

  4. Felber J, Golay A. Pathways from obesity to diabetes. Int J Obes. 2002;26:S39–S45.

    Article  CAS  Google Scholar 

  5. Sathyapalan T, Mellor D, Atkin SL. Obesity and gestational diabetes. Seminars in Fetal and Neonatal Medicine. 2010;15:89–93.

  6. Seravalle G, Grassi G. Obesity and hypertension. Pharmacolo Res. 2017;122:1–7.

    Article  CAS  Google Scholar 

  7. Jokinen E. Obesity and cardiovascular disease. Minerva Pediatr. 2014;67:25–32.

    PubMed  Google Scholar 

  8. McMillan DC, Sattar N, Lean M, McArdle CS. Obesity and cancer. BMJ. 2006;333:1109–11.

    Article  Google Scholar 

  9. Li Q, Blume SW, Huang JC, Hammer M, Ganz ML. Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States. J Med Econ. 2015;18:1020–8.

    Article  Google Scholar 

  10. Withrow D, Alter DA. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev. 2011;12:131–41.

    Article  CAS  Google Scholar 

  11. Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33:673–89.

    Article  Google Scholar 

  12. Mehrdad M, Vahid F, Shivappa N, Hébert JR, Fardaei M, Hassan Eftekhari M. High dietary inflammatory index (DII) scores increase odds of overweight in adults with rs9939609 polymorphism of FTO gene. Clin Nutr ESPEN. 2021;42:221–6.

    Article  Google Scholar 

  13. Saghafi-Asl M, Mirmajidi S, Asghari Jafarabadi M, Vahid F, Shivappa N, Hébert JR, et al. The association of dietary patterns with dietary inflammatory index, systemic inflammation, and insulin resistance, in apparently healthy individuals with obesity. Sci Rep. 2021;11:7515.

    Article  CAS  Google Scholar 

  14. Min M, Li-Fa X, Dong H, Jing W, Ming-Jie B. Dietary patterns and overweight/obesity: a review article. Iran J Public Health. 2017;46:869.

    Google Scholar 

  15. Marzullo P, Minocci A, Tagliaferri MA, Guzzaloni G, Di Blasio A, De, et al. Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants. J Clin Endocrinol Metab. 2010;95:3965–72.

    Article  CAS  Google Scholar 

  16. Clarke SF, Murphy EF, Nilaweera K, Ross PR, Shanahan F, O’Toole PW, et al. The gut microbiota and its relationship to diet and obesity. Gut Microbes. 2012;3:186–202.

    Article  Google Scholar 

  17. Delgado GTC, Tamashiro WMDSC. Role of prebiotics in regulation of microbiota and prevention of obesity. Food Res Int. 2018;113:183–8.

    Article  Google Scholar 

  18. Bulló M, Casas-Agustench P, Amigó-Correig P, Aranceta J, Salas-Salvadó J. Inflammation, obesity and comorbidities: the role of diet. Public Health Nutr. 2007;10:1164–72.

    Article  Google Scholar 

  19. Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas M-E. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016;8:1–12.

    Article  Google Scholar 

  20. Hosseini B, Saedisomeolia A, Allman-Farinelli M. Association between antioxidant intake/status and obesity: a systematic review of observational studies. Biol Trace Elem Res. 2017;175:287–97.

    Article  CAS  Google Scholar 

  21. Garcia-Diaz DF, Lopez-Legarrea P, Quintero P, Martinez JA. Vitamin C in the treatment and/or prevention of obesity. J Nutr Sci Vitaminol. 2014;60:367–79.

    Article  CAS  Google Scholar 

  22. Emami MR, Jamshidi S, Zarezadeh M, Khorshidi M, Olang B, Hezaveh ZS, et al. Can vitamin E supplementation affect obesity indices? A systematic review and meta-analysis of twenty-four randomized controlled trials. Clin Nutr. 2021;40:3201–9.

  23. Shen X-H, Tang Q-Y, Huang J, Cai W. Vitamin E regulates adipocytokine expression in a rat model of dietary-induced obesity. Exp Biol Med. 2010;235:47–51.

    Article  Google Scholar 

  24. Alcalá M, Sánchez-Vera I, Sevillano J, Herrero L, Serra D, Ramos MP, et al. Vitamin E reduces adipose tissue fibrosis, inflammation, and oxidative stress and improves metabolic profile in obesity. Obesity. 2015;23:1598–606.

    Article  Google Scholar 

  25. Vahid F, Rahmani D, Davoodi SH. Validation of Dietary Antioxidant Index (DAI) and investigating the relationship between DAI and the odds of gastric cancer. Nutr Metab. 2020;17:102.

    Article  CAS  Google Scholar 

  26. Zhang T, Andrukhov O, Haririan H, Müller-Kern M, Liu S, Liu Z, et al. Total antioxidant capacity and total oxidant status in saliva of periodontitis patients in relation to bacterial load. Front Cell Infect Microbiol. 2016;5:97.

  27. Stancliffe RA, Thorpe T, Zemel MB. Dairy attentuates oxidative and inflammatory stress in metabolic syndrome. Am J Clin Nutr. 2011;94:422–30.

    Article  CAS  Google Scholar 

  28. Vahid F, Rahmani D, Hekmatdoost A. The association between Dietary Antioxidant Index (DAI) and nonalcoholic fatty liver disease (NAFLD) onset; new findings from an incident case-control study. Clin Nutr ESPEN. 2021;41:360–4.

    Article  Google Scholar 

  29. Abdollahpour I, Nedjat S, Salimi Y, Mansournia MA, Vahid F, Weinstock-Guttman B. The role of Dietary Antioxidant Index and index of nutritional quality in MS onset: finding from an Iranian population-based incident case–control study. Nutr Neurosci. 2020:1–8.

  30. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317:1098.

    Article  CAS  PubMed  Google Scholar 

  31. Doaei S, Kalantari N, Izadi P, Salonurmi T, Jarrahi AM, Rafieifar S, et al. Interactions between macro-nutrients’ intake, FTO and IRX3 gene expression, and FTO genotype in obese and overweight male adolescents. Adipocyte. 2019;8:386–91.

    Article  CAS  Google Scholar 

  32. Doaei S, Kalantari N, Mohammadi NK, Izadi P, Gholamalizadeh M, Eini-Zinab H, et al. Up-regulation of FTO gene expression was associated with increase in skeletal muscle mass in overweight male adolescents. Arch Med Sci. 2019;15:1133–7.

    Article  CAS  Google Scholar 

  33. Ronkainen J, Huusko TJ, Soininen R, Mondini E, Cinti F, Mäkelä KA, et al. Fat mass- and obesity-associated gene Fto affects the dietary response in mouse white adipose tissue. Sci Rep. 2015;5:9233.

    Article  CAS  Google Scholar 

  34. Vahid F, Rahmani D, Davoodi SH, Hekmatdoost A. The association among Maternal Index of Nutritional Quality, Dietary Antioxidant Index, and Odds of Miscarriage Incidence: case-control study. J Am Coll Nutr. 2021:1–8.

  35. Rautiainen S, Levitan EB, Orsini N, Åkesson A, Morgenstern R, Mittleman MA, et al. Total Antioxidant Capacity from diet and risk of myocardial infarction: a prospective cohort of women. Am J Med. 2012;125:974–80.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr Diyako Rahmani for the technical editing of the article.

Author information

Authors and Affiliations

Authors

Contributions

FV and SHD designed and conducted research; FV analyzed the data; DR and FV drafted the paper; FV has primary responsibility for final content. All authors read and approved the final paper.

Corresponding author

Correspondence to Farhad Vahid.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

Arak University of Medical Science Ethics Committee, Arak, Iran, approved the study protocol (Ethics Committee No. IR.ARAKMU.REC.1398.094).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vahid, F., Rahmani, D. & Davoodi, S.H. The correlation between serum inflammatory, antioxidant, glucose handling biomarkers, and Dietary Antioxidant Index (DAI) and the role of DAI in obesity/overweight causation: population-based case–control study. Int J Obes 45, 2591–2599 (2021). https://doi.org/10.1038/s41366-021-00944-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41366-021-00944-w

This article is cited by

Search

Quick links